BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 15, 2003
View Archived Issues
Acambis Files 'First-Ever' BLA: Arilvax Vaccine In Yellow Fever
Acambis plc filed a biologics license application seeking approval of Arilvax as a vaccine to prevent yellow fever. (BioWorld Today)
Read More
Xanthus Series B Gets $30.8M To Advance Phase II Program
Read More
New-Found Proteins Cause Iron Overload Ailment In Body, But Presage Hemochromatosis Cure
Read More
VasGene Uses ASH Platform To Tout Anti-VEGF Cancer Product
Read More
Correction
Read More
Other News To Note
Read More